Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 7, 1998, Pages 597-603

  Liu, Shao Chen ^a   Sauter, Edward R ^a   Clapper, Margie L ^a   Feldman, Roy S ^b   Levin, Lawrence ^c   Chen, Sow Yeh ^d   Yen, Timothy J ^a   Ross, Eric ^a   Engstrom, Paul F ^a   Klein Szanto, Andres J P ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ASSOCIATED PROTEIN 1; CYCLIN D1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LEUKOPLAKIA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; TONGUE;

ANTIGENS, NUCLEAR; CARCINOMA IN SITU; CELL DIVISION; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN D1; EPITHELIAL CELLS; FEMALE; HUMANS; KI-67 ANTIGEN; LEUKOPLAKIA, ORAL; MALE; MICROFILAMENT PROTEINS; MOUTH MUCOSA; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 7344219818     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. WHO Collaborating Centre for Oral Precancerous Lesions Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol., 46: 518-539, 1978,
2. Burkhardt, A. Premaligne Veraenderungen der Mundschleimhaut. Der. Pathologe, 6: 126-132, 1985.
3. Warnakulasurya, K. A. A. S , and MacDonald, D. G. Epithelial cell kinetics in oral leukoplakia. J. Oral Pathol. Med . 24. 165-169, 1995.
4. Hill. M. W. Cell kinetics in premalignancy. In: I. Mackenzie, E. Dabelsteen, and C. S Squier (eds.), Oral Premalignancy, pp. 191-219. Iowa City, IA: University of Iowa Press, 1980.
5. Mittal, K R., Demopoulos, R. I, and Goswami, S. Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia Am. J. Surg Pathol., 17: 117-122, 1993.
6. Bulten, J, van der Laak, A. W. M., Gemmink, I. H., Pahlplatz, DeWilde, P. C. M., and Hanselaar, G. J. M. MIBI, a promising marker for the classification of cervical intraepithelial neoplasia, J. Pathol., 102- 268-273, 1996.
7. Crissman, J D Upper aerodigestive tract. in: D. E Henson and J AlboresSaavedra (eds.), Pathology of Incipient Neoplasia, pp. 44-63. Philadelphia: W. B. Saunders, 1993
8. Maidhof, R., Prantl, F., Hornstein, O. P., and Schell, H. Zur Proliferationskinetik der normalen und leukoplakisehen Wangenmucosa. Arch. Derrnatol Res , 260: 193-200, 1977.
9. Huang, W. Y , Coltrera, M., Schubert, M., Morton, T., and Truelove, E. Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions Oral Surg Oral Med. Oral Pathol., 78: 748-754, 1994.
10. Shin, D. M , Hittelman, W. N , and Hong, W. K. Biomarkers in upper aerodigestive trace tumorigenesis: a review. Cancer Epidemiol. Biomark. Prev , 3: 697-709, 1994.
11. Kobayashi, I., Matsuo, K., Ozeki. S., Ohishi, M., Ishbashi, Y., and Sakai, H. The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining Hum Pathol., 26. 907-913, 1995.
12. Wedenberg, C., Jonsson, A., and Jirsch, J. M. Assessment of p53 and Ki-67 expression in snuff-induced lesions Br. J. Oral Maxillofac. Surg., 34: 409-413, 1996.
13. Martinez-Lara, I., Gonzalez-Moles, M. A , Ruiz-Avila, I., Bravo, M., Ramos, M. C., and Fernandez-Martinez, J. A. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa. Acta Stomatol. Belg., 93: 29-32, 1996.
14. Lan, H A , Zain, R B , Saitoh, M., Muramatsu, Y., Shrestha, P., and Mori, M Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa: a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness? Anticancer Res., 16, 3059-3065, 1996.
15. Rishi, M., Schwarting, R., Kovatich, A. J., and Ehya, H Detecting the growth fraction in tumors by Ki67 monoclonal antibody in cytologic smears: a prospective study of 40 cases Diagn Cytopathol., 9: 52-58, 1992.
16. Tamboli, P., Amin, M B., Schultz, D S , Linden, M. D., and Kubus, J. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol, 9: 1015-1019, 1996.
17. Gallo, O , Franchi, A., Chiarelli, I., Porfirio, B., Grande, A., Simonetti. L., Bocciolini, C., and Fini-Storchi, O. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx. Acta Oto-Laryngol. Suppl., 557: 30-38, 1997.
18. Van Hoeven, K. H., Ramondetta, L., Kovatich, A, J., Bibbo, M., and Dunton, C. J. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J. Gynecol. Pathol., 16: 15-21, 1997.
19. Masuda, M., Hirakawa, N., Nakashima, T., Kuratomi, Y., and Komiyama, S. Cyclin DI overexpression in primary hypopharyngeal carcinomas Cancer (Phila), 78: 390-395, 1996.
20. Uhlman, D. L., Adams, G., Knapp, D., Aeppli, D. M., and Niehans, G. Immunohistochemical staining for markers of future neoplastic progression in the larynx Cancer Res., 56: 2199-2205, 1996.
21. Landberg, G., Erlanson, M., Roos, G., Tan, E. M., and Casiano, C. A The nuclear autoantigen p330d/CENP-F: a marker for cell proliferation in human malignancies. Cytometry, 25: 90-98, 1996.
22. Gerdes, J , Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., and Stein, H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol., 133: 1710-1715, 1984.
23. Sherr, C J. D-type cyclins. Trends Biochem Sci., 20: 187-190, 1995.
24. Callender, T., El-Naggar, A. K , Lee, M. S , Frankenthaler, R., Luna, M. A., and Batsakis, J. G PRAD-1 (CCND1)/cyclin Dl oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
25. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Traserra, J, and Cardesa, A. PRAD-1/cyclin DI gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
26. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
27. Michalides, R., van Veelen, N., Hart, A , Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin DI correlates with recurrence in a group of fortyseven operable squamous cell carcinomas of the head and neck. Cancer Res., 55-975-978, 1995
28. Bellacosa, A., Almadori, G., Cavallo, S., Cadoni, G., Galli, J , Ferrandina, G , Scambia, G , and Neri, G Cyclin DI gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications Clin Cancer Res., 2: 175-180, 1996.
29. 2 and is rapidly degraded after mitosis. J Cell Biol., 130: 507-518, 1995.
30. Shin, D. M., Voravud, N , Ro, J. Y., Lee, J. S., Hong, W K., and Hittleman, W. N. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis-a potential biomarker J Natl Cancer Inst, 85: 971-978, 1993
31. Liang, K. Y., and Zeger, S. Longitudinal data analysis using generalized linear models. Biometrika, 73: 13-22, 1986
32. Loe, H, Karring, T., and Hara, K. The site of mitotic activity in rat and human oral epithelium. Scand J Dent. Res., 80: 111-119, 1972.
33. Rodriguez-Perez, I., Sanabria-Negrin, J , and Banoczy, J. Oral leukoplakia: nuclear volume and mitotic index Acta Morphol. Hung , 32: 245-249, 1984
34. Maidhof, R., and Hornstein, O. P. Autoradiographic study and some proliferative properties of human buccal mucosa. Arch Dermatol. Res., 265: 165-172, 1979.
35. Kotelnikov, V. M., Coon, J. S., Taylor, S., Hutchinson, J , Panje, W., Caldarelli, D. D , LaFollette, H., and Priesler, H D. In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region. Cell Prolif, 28: 497-509, 1995
36. Skougaard, A O., Skougaard, M R., Pindborg, J. J., and Roed-Petersen, B. In vitro incorporation of tritiated thymidine in homogeneous leukoplakias. Scand. J Dent. Res., 80. 510-514, 1972.
37. Alvares, O. F., and Meyer, J Variable features and regional differences in oral epithelium. In: C. A. Squier and J. Meyer (eds.), Current Concepts of the Histology of Oral Mucosa, pp. 97-113 Springfield, TL- Charles Thomas, 1971.
38. Klein-Szanto, A J. P., and Schroeder, H. E. Architecture and density of the connective tissue papillae of the human oral mucosa. J. Anat., 123: 93-109, 1977.
39. MacDonald, D. G. Cell renewal in oral epithelium. In: C. A Squier and J. Meyer (eds.), Current Concepts of the Histology of Oral Mucosa, pp. 61-79. Springfield, IL: Charles Thomas, 1971.
40. Klein-Szanto, A. J. P., Banoczy, J., and Schroeder, H E. Metaplasric conversion of the differentiation pattern in oral epithelia affected by leukoplakia simplex A stereologic study Pathol Eur, 11: 189-210, 1976.
41. Renstrup, G. Studies in oral leukoplakias IV Mitotic activity. Acta Odontol. Scand , 21: 233-340, 1963.
42. Coltrera, M D., Zarbo, R J , Sakr, W. A., and Gown, A M Markers for dysplasia of the upper aerodigestive tract Suprabasal expression of PCNA. p53, and CK19 in alcohol-fixed, embedded tissue Am. J. Pathol., 141: 817-825,1992.